Ascend Wellness Holdings (AAWH) Enterprise Value (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Enterprise Value of -$60.1 million for Q1 2026, up 39.43% year-over-year from -$43.1 million in Q1 2025, and up 29.18% quarter-over-quarter from -$84.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Enterprise Value (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$60.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 39.43% year-over-year to -$60.1 million; the TTM figure through Mar 2026 stood at -$60.1 million (up 39.43% YoY), while the FY2025 annual figure was -$84.9 million, up 2.95% from the prior year.
- Enterprise Value for Q1 2026 stood at -$60.1 million, up from -$84.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$60.1 million in Q1 2026, with the low at -$143.8 million in Q1 2022.
- The 5-year median for Enterprise Value is -$82.7 million (2024), against an average of -$85.8 million.
- Peak annual rise in Enterprise Value reached 52.31% in 2022, while the deepest fall reached 129.59% in 2022.
- Ascend Wellness Holdings' Enterprise Value stood at -$74.1 million in 2022, then rose by 2.21% to -$72.5 million in 2023, then declined by 20.58% to -$87.4 million in 2024, then gained by 2.95% to -$84.9 million in 2025, then advanced by 29.18% to -$60.1 million in 2026.
- Business Quant data shows AAWH's Enterprise Value at -$60.1 million in Q1 2026, -$84.9 million in Q4 2025, and -$86.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | -164.00 Mn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | -66.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.18 Mn |
| Mar 31, 2026 | -60.10 Mn |
| Dec 31, 2025 | -84.85 Mn |
| Sep 30, 2025 | -86.45 Mn |
| Jun 30, 2025 | -94.45 Mn |
| Mar 31, 2025 | -99.21 Mn |
| Dec 31, 2024 | -87.43 Mn |
| Sep 30, 2024 | -64.46 Mn |
| Jun 30, 2024 | -82.66 Mn |
| Mar 31, 2024 | -71.85 Mn |
| Dec 31, 2023 | -72.51 Mn |
| Sep 30, 2023 | -63.92 Mn |
| Jun 30, 2023 | -68.05 Mn |
| Mar 31, 2023 | -73.30 Mn |
| Dec 31, 2022 | -74.15 Mn |
| Sep 30, 2022 | -91.39 Mn |
| Jun 30, 2022 | -140.55 Mn |
| Mar 31, 2022 | -143.80 Mn |
| Dec 31, 2021 | -155.48 Mn |
| Mar 31, 2021 | -62.63 Mn |